
Health Shouldn’t Take Detours
Pioneers in Developing Innovative Rapid Tests
We bring diagnostics out of the laboratory and into everyday life – closer to people, where it truly matters. Together with healthcare professionals, research partners, and users, we are reshaping how health is monitored and understood.
20+ years of experience
In more than 30 countries
Over 30+ biomarkers
1000+ partners worldwide
Shaping the Future of Diagnostics
Our aim is to simplify prevention, reduce the burden on clinics and medical practices, and improve access to testing. We bring diagnostics closer to where health decisions are made – at home, in pharmacies, medical practices and clinics.

What Drives Us
Making Health Tangible for Everyone
Scientifically Grounded
Our tests have been evaluated by recognised institutions such as the German Cancer Research Center (DKFZ).
User-Centred
Our products evolve from the challenges pharmacies, clinics and patients face everyday.
Future-Oriented
We rethink conventional methods and reduce barriers because diagnostics should work for people – not the other way around.
Over 20 Years of Experience
From Laboratory Diagnostics to Digital Patient Care
Preventis was founded in 2003 and has its roots in laboratory diagnostics. In the beginning, we focused on making diagnostic information available faster and developed qualitative rapid tests for use at the point of care. Yet not every diagnostic question can be answered with a simple positive or negative result. In chronic diseases in particular, quantitative values are often needed. This challenge becomes especially apparent in people with Crohn’s disease or ulcerative colitis. When a flare-up is suspected, the calprotectin level provides important information for further assessment. For a long time, obtaining this value involved a lengthy process: visiting the practice, collecting a test kit, taking a stool sample at home, sending the sample to a laboratory and then waiting for the result. This led us to a central question: Why should a quantitative measurement be tied exclusively to a laboratory? This question marked the beginning of our SmarTest technology. In 2015, we reached an important milestone with our first smartphone-assisted quantitative calprotectin rapid test: results within 15 minutes, directly at home, with the option to share them digitally with the treating center. This created new possibilities for integrating home-based diagnostics into telemedical care. Since then, we have continued to develop this approach, expanding the SmarTest product range to enable quantitative measurement of additional biomarkers.
From Development to Application
The Science Behind Every Test
Scientifically grounded diagnostics begin with a deep understanding of what each test measures: the analyte, its clinical relevance, and factors that may influence the result. This knowledge guides our development process from the very beginning.
We are Preventis!
Shape the Future of Healthcare with Us
Behind Preventis is a team spanning research, development, production, marketing, software and regulatory affairs. As a MedTech company, we work across disciplines and focus on solutions – from the initial idea through to product launch. Every department contributes its own perspective. At Preventis, expertise matters, but so does the willingness to explore new approaches. We believe in bright minds who stay curious and take responsibility. Join us in shaping the healthcare of tomorrow.
Our Partners
United by a Shared Mission
With some companies, our relationship goes far beyond a simple collaboration. As part of the same group of companies, Immundiagnostik AG, Liftric, BioAssay Works, and Preventis form a closely connected partner network with complementary expertise across diagnostics, software engineering, and assay development. For assay development and clinical validation, we work closely with Immundiagnostik AG. Together with Liftric, we developed the SmarTest product line and its digital infrastructure. BioAssay Works contributes high-sensitivity gold nanoparticle technology to the development and manufacturing of our rapid lateral flow tests.
Backed by Clinical Studies
Vitamin D: lab comparison
Calprotectin: lab comparison​
Calprotectin: usability study
FIT: DKFZ study
Nail fungus: SEIMC study

Let’s Advance Patient Care – Together
- Innovative point-of-care solutions that support efficient workflows and reduce the burden on patients
- Scientifically validated and compliant with IVDR requirements
- Developed and manufactured in Germany














